decreased total body fat amount_Vipr2<tm1Hmh>/Vipr2<tm1Hmh>

http://metadb.riken.jp/0010025I129P2OlaHsdC57BL6Vipr2tm1HmhVipr2tm1HmhVipr2tm1Hmh

decreased total body fat amount_Vipr2<tm1Hmh>/Vipr2<tm1Hmh>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• vasoactive intestinal peptide receptor 2
  http://metadb.riken.jp/db/mgi_rdf/MGI:107166

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Vipr2<tm1Hmh>/Vipr2<tm1Hmh>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Vipr2<tm1Hmh>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129P2/OlaHsd * C57BL/6

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• decreased total body fat amount
  http://purl.obolibrary.org/obo/MP_0010025

文献

http://purl.org/net/cito/citesAsAuthority

• Mark A. Asnicar, et.al., Vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating peptide receptor 2 deficiency in mice results in growth retardation and increased basal metabolic rate., Endocrinology, 2002, 143
  http://rdf.ncbi.nlm.nih.gov/pubmed/12239111